Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events

Linnea M. Baudhuin, Katrina E. Kotzer, Susan A. Lagerstedt

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Purpose: Marfan syndrome is a systemic disorder that typically involves FBN1 mutations and cardiovascular manifestations. We investigated FBN1 genotype-phenotype correlations with aortic events (aortic dissection and prophylactic aortic surgery) in patients with Marfan syndrome. Methods: Genotype and phenotype information from probands (n = 179) with an FBN1 pathogenic or likely pathogenic variant were assessed. Results: A higher frequency of truncating or splicing FBN1 variants was observed in Ghent criteria-positive patients with an aortic event (n = 34) as compared with all other probands (n = 145) without a reported aortic event (79 vs. 39%; P < 0.0001), as well as Ghent criteria-positive probands (n = 54) without an aortic event (79 vs. 48%; P = 0.0039). Most probands with an early aortic event had a truncating or splicing variant (100% (n = 12) and 95% (n = 21) of patients younger than 30 and 40 years old, respectively). Aortic events occurred at a younger median age in patients with truncating/splicing variants (29 years) as compared with those with missense variants (51 years). A trend toward a higher frequency of truncating/splicing variants in patients with aortic dissection (n = 21) versus prophylactic surgery (n = 13) (85.7 vs. 69.3%; not significant) was observed. Conclusion: These aortic event- and age-associated findings may have important implications for the management of Marfan syndrome patients with FBN1 truncating and splicing variants.

Original languageEnglish (US)
Pages (from-to)177-187
Number of pages11
JournalGenetics in Medicine
Volume17
Issue number3
DOIs
StatePublished - Mar 1 2015

Fingerprint

Marfan Syndrome
Dissection
Genetic Association Studies
Genotype
Phenotype
Mutation

Keywords

  • aortic dissection
  • aortic surgery
  • FBN1
  • fibrillin-1
  • Marfan syndrome

ASJC Scopus subject areas

  • Genetics(clinical)
  • Medicine(all)

Cite this

Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. / Baudhuin, Linnea M.; Kotzer, Katrina E.; Lagerstedt, Susan A.

In: Genetics in Medicine, Vol. 17, No. 3, 01.03.2015, p. 177-187.

Research output: Contribution to journalArticle

Baudhuin, Linnea M. ; Kotzer, Katrina E. ; Lagerstedt, Susan A. / Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. In: Genetics in Medicine. 2015 ; Vol. 17, No. 3. pp. 177-187.
@article{cebec6df6d1844699bb6e3347b39e34d,
title = "Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events",
abstract = "Purpose: Marfan syndrome is a systemic disorder that typically involves FBN1 mutations and cardiovascular manifestations. We investigated FBN1 genotype-phenotype correlations with aortic events (aortic dissection and prophylactic aortic surgery) in patients with Marfan syndrome. Methods: Genotype and phenotype information from probands (n = 179) with an FBN1 pathogenic or likely pathogenic variant were assessed. Results: A higher frequency of truncating or splicing FBN1 variants was observed in Ghent criteria-positive patients with an aortic event (n = 34) as compared with all other probands (n = 145) without a reported aortic event (79 vs. 39{\%}; P < 0.0001), as well as Ghent criteria-positive probands (n = 54) without an aortic event (79 vs. 48{\%}; P = 0.0039). Most probands with an early aortic event had a truncating or splicing variant (100{\%} (n = 12) and 95{\%} (n = 21) of patients younger than 30 and 40 years old, respectively). Aortic events occurred at a younger median age in patients with truncating/splicing variants (29 years) as compared with those with missense variants (51 years). A trend toward a higher frequency of truncating/splicing variants in patients with aortic dissection (n = 21) versus prophylactic surgery (n = 13) (85.7 vs. 69.3{\%}; not significant) was observed. Conclusion: These aortic event- and age-associated findings may have important implications for the management of Marfan syndrome patients with FBN1 truncating and splicing variants.",
keywords = "aortic dissection, aortic surgery, FBN1, fibrillin-1, Marfan syndrome",
author = "Baudhuin, {Linnea M.} and Kotzer, {Katrina E.} and Lagerstedt, {Susan A.}",
year = "2015",
month = "3",
day = "1",
doi = "10.1038/gim.2014.91",
language = "English (US)",
volume = "17",
pages = "177--187",
journal = "Genetics in Medicine",
issn = "1098-3600",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events

AU - Baudhuin, Linnea M.

AU - Kotzer, Katrina E.

AU - Lagerstedt, Susan A.

PY - 2015/3/1

Y1 - 2015/3/1

N2 - Purpose: Marfan syndrome is a systemic disorder that typically involves FBN1 mutations and cardiovascular manifestations. We investigated FBN1 genotype-phenotype correlations with aortic events (aortic dissection and prophylactic aortic surgery) in patients with Marfan syndrome. Methods: Genotype and phenotype information from probands (n = 179) with an FBN1 pathogenic or likely pathogenic variant were assessed. Results: A higher frequency of truncating or splicing FBN1 variants was observed in Ghent criteria-positive patients with an aortic event (n = 34) as compared with all other probands (n = 145) without a reported aortic event (79 vs. 39%; P < 0.0001), as well as Ghent criteria-positive probands (n = 54) without an aortic event (79 vs. 48%; P = 0.0039). Most probands with an early aortic event had a truncating or splicing variant (100% (n = 12) and 95% (n = 21) of patients younger than 30 and 40 years old, respectively). Aortic events occurred at a younger median age in patients with truncating/splicing variants (29 years) as compared with those with missense variants (51 years). A trend toward a higher frequency of truncating/splicing variants in patients with aortic dissection (n = 21) versus prophylactic surgery (n = 13) (85.7 vs. 69.3%; not significant) was observed. Conclusion: These aortic event- and age-associated findings may have important implications for the management of Marfan syndrome patients with FBN1 truncating and splicing variants.

AB - Purpose: Marfan syndrome is a systemic disorder that typically involves FBN1 mutations and cardiovascular manifestations. We investigated FBN1 genotype-phenotype correlations with aortic events (aortic dissection and prophylactic aortic surgery) in patients with Marfan syndrome. Methods: Genotype and phenotype information from probands (n = 179) with an FBN1 pathogenic or likely pathogenic variant were assessed. Results: A higher frequency of truncating or splicing FBN1 variants was observed in Ghent criteria-positive patients with an aortic event (n = 34) as compared with all other probands (n = 145) without a reported aortic event (79 vs. 39%; P < 0.0001), as well as Ghent criteria-positive probands (n = 54) without an aortic event (79 vs. 48%; P = 0.0039). Most probands with an early aortic event had a truncating or splicing variant (100% (n = 12) and 95% (n = 21) of patients younger than 30 and 40 years old, respectively). Aortic events occurred at a younger median age in patients with truncating/splicing variants (29 years) as compared with those with missense variants (51 years). A trend toward a higher frequency of truncating/splicing variants in patients with aortic dissection (n = 21) versus prophylactic surgery (n = 13) (85.7 vs. 69.3%; not significant) was observed. Conclusion: These aortic event- and age-associated findings may have important implications for the management of Marfan syndrome patients with FBN1 truncating and splicing variants.

KW - aortic dissection

KW - aortic surgery

KW - FBN1

KW - fibrillin-1

KW - Marfan syndrome

UR - http://www.scopus.com/inward/record.url?scp=84938508858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938508858&partnerID=8YFLogxK

U2 - 10.1038/gim.2014.91

DO - 10.1038/gim.2014.91

M3 - Article

VL - 17

SP - 177

EP - 187

JO - Genetics in Medicine

JF - Genetics in Medicine

SN - 1098-3600

IS - 3

ER -